HHS Secretary Signs COVID-19 Emergency Use Authorization Declaration Terminations
On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
On Jun. 22, 2026, Federal health officials announced a pilot program Monday to speed up early-stage clinical trials,…
On Jun. 18, 2026, a new kind of flu vaccine moved a step closer to the U.S. market…
On Jun. 16, 2026, the U.S. Food and Drug Administration (FDA) approved another over-the-counter (OTC) intranasal naloxone product,…
On Jun. 11, 2026, The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for generic…
On Jun. 9, 2026, the U.S. Food and Drug Administration (FDA) announced it has added bemotrizinol to the…
On Jun. 2, 2026, The Florida Department of Health said there have been 154 measles cases in the…
On May 29, 2026, the U.S. Centers for Disease Control and Prevention (CDC) confirmed 31 new measles cases…
On May 25, 2026, Virginia Tech researchers announced they have received Food and Drug Administration (FDA) approval for…
On Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…
On Apr. 28, 2026, The U.S. Food and Drug Administration announced two major steps as part of an…
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
On Apr. 21, 2026, the annual influenza vaccines are no longer mandatory, said Pete Hegseth in a video…
On Apr. 1, 2026, Eli Lilly announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for…
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
On Mar. 18, 2026, Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device…
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
On Mar. 13, 2026, GSK announced that the US Food and Drug Administration (FDA) has expanded the approved…
On Mar. 11, 2026, the U.S. Food and Drug Administration (FDA) announced it is implementing the Adverse Event…
On Mar. 10, 2026, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for…
On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…
On Feb. 27, 2026, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved three…
On Feb. 9, 2026, the Oregon Health and Science University (OHSU) board of directors unanimously passed a resolution…
On Jan. 29, 2026, in a new study from Sweden, researchers found no statistically significant difference in rates…
On Jan. 28, 2026, the U.S. Environmental Protection Agency (EPA) launched the first step of its expedited review…
On Jan. 22, 2026, The U.S. has finalized its withdrawal from the World Health Organization (WHO), one year…
On Jan. 21, 2026, the Centers for Disease Control and Prevention (CDC) report the percentage of adults age…